Protein Geranylgeranyltransferase Type 1 as a Target in Cancer

E-ISSN： 1873-5576|16|7|563-571

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.16, Iss.7, 2016-08, pp. : 563-571

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stathmin 1: a protein with many tasks. New biomarker and potential target in cancer

By Nemunaitis John

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 7, 2012-07 ,pp. : 631-634

Informa Healthcare

Access to resources Recommend Favorite

The Protein Acetyltransferase ARD1: A Novel Cancer Drug Target?

Current Cancer Drug Targets, Vol. 8, Iss. 7, 2008-11 ,pp. : 545-553

Bentham Science Publishers

Access to resources Recommend Favorite

Protein Tyrosine Phosphatase 1B: A Novel Target for Type 2 Diabetes and Obesity

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 7, 2003-03 ,pp. : 749-757

Bentham Science Publishers

Access to resources Recommend Favorite

The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design?

By McCluskey A. Ackland1 S.P. Gardiner E. Walkom C.C. Sakoff1 J.A.

Anti-Cancer Drug Design, Vol. 16, Iss. 6, 2001-12 ,pp. : 291-303

Cognizant Communication Corporation

Access to resources Recommend Favorite

The role of dynamin-related protein 1 in cancer growth: a promising therapeutic target?

By Qian Wei

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 9, 2013-09 ,pp. : 997-1001

Informa Healthcare

Access to resources Recommend Favorite